true
- Overview
- Acute Care Facilities
- Alternate Sites
- FAQs
- Resources
The FDA safety notice regarding plastic syringes manufactured in China does not apply to any BD syringes. BD is the only major manufacturer of hypodermic syringes supporting the U.S. market that manufactures primarily in the U.S. BD stands ready to increase production to help supply impacted providers.
Choose confidently
We know clinicians have a choice. When making that choice, the details make all the difference. For over 125 years, BD has built a legacy of performance, trust and consistency—providing a comprehensive portfolio of high-quality products more widely used by healthcare professionals than any other brand.
So clinicians can choose confidently.
A legacy of performance and trust
#1 selling needle and syringe portfolio in the U.S.
BD manufactures more needles and syringes than any other brand
BD offers a comprehensive portfolio of safety injection products to fit your specific needs
BD syringes are validated for use on most major infusion pump brands,* including the BD Alaris™ Infusion Pump
*Check with syringe pump manufacturer or syringe pump manual for compatibility of syringe with specific syringe infusion pumps.
Hypodermic solutions you can count on
To deliver quality care 24/7, you need hypodermic products you can depend on every time. BD hypodermic solutions deliver the reliability, compatibility and adaptability you need.
98% of BD hypodermic customers surveyed globally agree that the BD brand stands for consistent, high quality…and that they would recommend BD products to their colleagues.
Supporting supply continuity
Having the right hypodermic solutions on hand when you need them is critical. That’s why we’ve taken multiple significant actions to support reliability and continuity of supply.
$75 million+
investment in Nebraska plants since 2018 to expand injection device capacity
3 billion+
needles and syringes are produced by BD every year for the U.S. market capacity
Click below to view the comprehensive Safety and Conventional Hypodermic SKU updates
Strategically positioned manufacturing to support your needs
1,600 U.S.-based manufacturing employees in Canaan, CT and Columbus, NE
Get to know Dustin #1
Get to know Dustin #2
Get to know Kurt
Get to know Dustin #3
Get to know Jeanine
Get to know Cathy
BD Hypodermic Portfolio Simplification Video
Get to know Dustin #1
Get to know Dustin #2
Get to know Kurt
Get to know Dustin #3
Get to know Jeanine
Get to know Cathy
BD Hypodermic Portfolio Simplification Video
-
BD® Conventional Needles and Syringes are designed and manufactured to deliver consistent quality and reliable performance.
-
BD SafetyGlide™ Needles have Activation Assist technology, making a safe injection easier and more efficient
-
The BD Eclipse™ Needle is easy to use with minimal training, and supports streamlined and cost-effective option for every practitioner, every day*
-
BD® Blunt Fill and Blunt Filter Needles help reduce the risk of needlestick injuries during medication preparation due to a higher skin penetration force**
-
The BD Integra™ Retracting Syringe is designed to have low waste space. Low waste space may result in reduced medication waste as compared to a traditional syringe and needle.
-
The BD SafetyGlide™ Syringe for TB and Allergy is specifically designed to deliver small doses of medication, while helping keep clinicians and patients safe.
*Within the BD safety hypodermic portfolio
**As compared to a BD 18 G conventional hypodermic needle
BD-113223 (07/24)
Consistency you can count on
Every day in an acute care facility brings different challenges and patients. As you adapt, you depend on consistency from your hypodermic needles and syringes—in quality, performance and supply.
From devices designed to advance healthcare worker safety and support safe pump infusions to assessments focused on standardization and risk reduction, BD is committed to providing the high quality hypodermic solutions you can count on, for each patient and every procedure.
The cost of switching to safety-engineered devices (SEDs) from conventional devices isn’t simply a comparison of prices. For needlestick injuries (NSIs), every incident carries potential clinical and emotional burdens for healthcare workers and economic burden for healthcare systems.
Sharps
injuries
injuries
Exposure
risk
risk
Disease
transmission
transmission
Economic
burden
burden
Take control of healthcare worker safety
The use of safety-engineered devices (SEDs) has been proven to prevent needlestick injuries.
-
93% reduction in needlestick injuries when safety devices were used. Education and training were key factors4
-
80% of injection/venipuncture administration injuries that could have “probably” or “definitely” been prevented by safety devices5
Designed for your safety
Through our broad portfolio of safety-engineered devices, BD is committed to helping clinicians and institutions meet clinical needs and transform safety at each step of the care continuum.
- U.S. leader of safety injection devices and syringes
- A broad portfolio of safety injection technology
Take the first step toward improved outcomes
The BD Medication Preparation and Delivery Assessment is designed to help standardize safety device utilization and reinforce best practices through a detailed, actionable road map of BD product recommendations and training—which may help to reduce potential risk factors affecting NSI rates and costs.
-
Proven methodology
-
Proprietary tools
-
Best practices recommendations
- Centers for Disease Control and Prevention. 2008 Sharps Injury Prevention Workbook. Accessed on March 15, 2023, at https://www.cdc.gov/sharpssafety/pdf/workbookcomplete.pdf.
- Occupational Safety and Health Administration. United States Department of Labor. Hazard Recognition. Accessed on March 15, 2023, at http://www.osha.gov/bloodborne-pathogens/hazards#.
- Occupational Safety and Health Administration. United States Department of Labor. Bloodborne Pathogens and Needlestick Prevention. Accessed on March 15, 2023, at http://www.osha.gov/bloodbornepathogens#.
- De Carli G, Abiteboul D, Puro V. The importance of implementing safe sharps practices in the laboratory setting in Europe. Biochem Med (Zagreb). 2014;24(1):45-56. Published 2014 Feb 15. doi:10.11613/BM.2014.007.
- Cullen BL, Genasi F, Symington I, et al. Potential for reported needlestick injury prevention among healthcare workers through safety device usage and improvement of guideline adherence: expert panel assessment. J Hosp Infect. 2006;63(4):445-451. doi:10.1016/j.jhin.2006.04.008.
BD-113223 (07/24)
Reliability, safety and efficiency
Whether administering medication or delivering vaccines, you rely on hypodermic needles and syringes multiple times a day, every day. BD is committed to providing high quality hypodermic solutions that deliver the reliable performance you need, with the enhanced safety and efficiency you deserve.
Supporting your needs and advancing supply reliability with strategically positioning manufacturing
Your partner in vaccinations
BD has been by the side of vaccine developers and healthcare providers for decades, ensuring the availability and safe administration of vaccines from polio and COVID-19 to the seasonal flu.
With a full suite of syringes and safety injection needles designed to help improve the patient experience, you can be confident that there is a BD hypodermic solution to meet your vaccination needs.
-
BD SafetyGlide™ Needles have Activation Assist technology, making a safe injection easier and more efficient
-
The BD Eclipse™ Needle is easy to use with minimal training, and supports streamlined and cost-effective option for every practitioner, every day*
*Within the BD safety hypodermic portfolio
The FDA safety notice does not apply to any BD Syringes. Essentially all hypodermic syringes BD provides to the U.S. healthcare system are manufactured in the U.S. in Nebraska and Connecticut.
Essentially all plastic syringes BD provides to the U.S. healthcare system are manufactured in the United States in Nebraska and Connecticut. BD does not manufacture or source syringes from China for the U.S. market.
BD has placed all syringes and syringe/needle combination products on manual allocation. BD will allocate distributors based on historical utilization to help prevent stockpiling.
The FDA safety notice is regarding plastic syringes manufactured in China. At this time, glass syringes, pre-filled syringes or syringes used for oral or topical purposes are not included.
If customers have questions on a specific clinical application, they should call BD Medical Information at 1-800-555-7422.
Unfortunately, this is another example of a market disruption due to quality and performance issues. Ensuring the safety and quality of our products is the top priority for BD.
BD has increased production at our Connecticut and Nebraska plants and remains committed to supporting the U.S. healthcare system to help supply those providers who currently purchase syringes impacted by the FDA communication. BD is in the process of ramping up capacity to meet potential demand. We are making every effort to understand the immediate and long-term needs of the U.S. market and we are urging our customers and distributors to place orders as soon as possible.
Pump manufacturers are responsible for determining whether syringes are compatible through a rigorous validation process. Users should check with the syringe pump manufacturer or syringe pump manual for compatibility of syringe with specific syringe infusion pumps.
As partners in healthcare, BD remains focused on providing the best products and solutions to meet your needs. We have done extensive analysis to confirm our product portfolio closely aligns with established best practices and clinical standards. We are committed to delivering an exceptional customer experience, making it easier for you to do business with us.
- Making strategic decisions about the BD portfolio may increase predictability of supply and demand, as well as the speed in which BD can deliver products to you.
- BD will continue to invest in new, innovative technologies that best meet your most critical needs.
- Studies have suggested that product standardization at hospitals can result in significant cost reduction, greater efficiency and increased patient-centered outcomes.
BD offers the needle lengths clinicians use most, and those that align with industry guidelines. The needle lengths clinicians rely on, and those needed most, will remain available, including: 0.375”, 0.5”, 0.625”, 1”, 1.5” and 2”.
The optimized BD hypodermic portfolio includes needle sizes that meet a variety of clinical applications, including: 16 G, 18 G, 21 G, 23 G, 25 G, 27 G and 30 G needles.
Streamlined needle lengths and gauges, which may help with:1,2
- Standardization
- Streamlined ordering processes
- Improved operations
- Reduced storage costs
- Rosser M. Advancing health system integration through supply chain improvement. Healthc Q. 2006;9(1):62-66.
- McKesson. Leveraging Product Standardization for Health System Efficiency. February 20, 2018. https://mms.mckesson.com/Blog/Leveraging-Product-Standardization-for-Health-System-Efficiency/. Accessed July 27, 2021.
BD-113223 (07/24)
-
BD® Conventional Needles and Syringes are designed and manufactured to deliver consistent quality and reliable performance.
-
BD SafetyGlide™ Needles have Activation Assist technology, making a safe injection easier and more efficient
-
The BD Eclipse™ Needle is easy to use with minimal training, and supports streamlined and cost-effective option for every practitioner, every day*
-
BD® Blunt Fill and Blunt Filter Needles help reduce the risk of needlestick injuries during medication preparation due to a higher skin penetration force**
-
The BD Integra™ Retracting Syringe is designed to have low waste space. Low waste space may result in reduced medication waste as compared to a traditional syringe and needle.
-
The BD SafetyGlide™ Syringe for TB and Allergy is specifically designed to deliver small doses of medication, while helping keep clinicians and patients safe.
*Within the BD safety hypodermic portfolio
**As compared to a BD 18 G conventional hypodermic needle
BD-113223 (07/24)
true